# Anixa Biosciences Inc: Form 8-K, filed Oct 4, 2021

- Company: [Anixa Biosciences Inc](/companies/anix.md) (CIK 715446)
- Form: 8-K
- Filed: 2021-10-04
- Accepted by EDGAR: Oct 4, 2021, 07:00 ET
- Period: 2021-10-01
- Accession: 0001493152-21-024422
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/715446/000149315221024422/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/715446/000149315221024422/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/715446/000149315221024422/form8-k.htm

Filed Oct 4, 2021.
Source: SEC EDGAR, the filing index for accession 0001493152-21-024422. Last ingested by Listed: Nov 2, 2026, 08:56 ET. No prices; not investment advice.